Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-17

Clinical Trial Update: The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating luteinizing hormone supplementation after GnRH antagonist use in advanced reproductive aging women undergoing IVF with embryo transfer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luveris (lutropin alfa)

Snippet

Sponsor: The Baruch Padeh Medical Center, Poriya | Conditions: Pregnancy Result Rape | Phase 4 | Status: COMPLETED